Simon Dumesnil's most recent trade in Pasithea Therapeutics Corp was a trade of 7,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 1, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Pasithea Therapeutics Corp | Simon Dumesnil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
Pasithea Therapeutics Corp | Simon Dumesnil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
Pasithea Therapeutics Corp | Simon Dumesnil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 100,000 | 100,000 | - | - | Stock Option (to acquire Common Stock) | |
Pasithea Therapeutics Corp | Simon Dumesnil | Director | Grant, award, or other acquisition of securities at price $ 1.06 per share. | 15 Nov 2022 | 40,000 | 50,000 | - | 1.1 | 42,400 | Common Stock |
Pasithea Therapeutics Corp | Simon Dumesnil | Director | Grant, award, or other acquisition of securities at price $ 1.07 per share. | 15 Nov 2022 | 10,000 | 10,000 | - | 1.1 | 10,700 | Common Stock |